interleukin-8 and istradefylline

interleukin-8 has been researched along with istradefylline* in 1 studies

Other Studies

1 other study(ies) available for interleukin-8 and istradefylline

Article	Year
Istradefylline, an adenosine A2a receptor antagonist, inhibits the CD4 Immunological medicine, 2022, Volume: 45, Issue:4 Extracellular adenosine produced from ATP plays a role in energy processes, neurotransmission, and inflammatory responses. Istradefylline is a selective adenosine A2a receptor (A2aR) antagonist used for the treatment of Parkinson's disease. We previously showed using mouse models that adenosine primes hypersecretion of interleukin (IL)-17A Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; CD4-Positive T-Lymphocytes; Humans; Inflammation; Interleukin-17; Interleukin-8; Leukocytes, Mononuclear; Mice; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; T-Lymphocytes	2022

Article

Year

Istradefylline, an adenosine A2a receptor antagonist, inhibits the CD4

Immunological medicine, 2022, Volume: 45, Issue:4

Extracellular adenosine produced from ATP plays a role in energy processes, neurotransmission, and inflammatory responses. Istradefylline is a selective adenosine A2a receptor (A2aR) antagonist used for the treatment of Parkinson's disease. We previously showed using mouse models that adenosine primes hypersecretion of interleukin (IL)-17A

Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; CD4-Positive T-Lymphocytes; Humans; Inflammation; Interleukin-17; Interleukin-8; Leukocytes, Mononuclear; Mice; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; T-Lymphocytes

2022